Medtronic Plc's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Medtronic Plc's ROA in the first quarter of 2026?
Medtronic Plc achieved a return on average assets (ROA) of 5.77 % in its first quarter of 2026, which is below Medtronic Plc's average return on assets, which stands at 7.39%.

ROA has improved compared to 5.33% in the fourth quarter of 2026, due to net income growth.

However, within the Healthcare sector 170 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 1152 to 1351.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 31 2026) I. Quarter	(Apr 24 2026) IV. Quarter	(Jan 23 2026) III. Quarter	(Oct 24 2025) II. Quarter	(Jul 25 2025) I. Quarter
Y / Y Total Assets Change	2.57 %	1.25 %	1.52 %	5.64 %	5.54 %
Y / Y Net Income Change	41.26 %	18.66 %	-11.74 %	8.06 %	-0.19 %
Net Income (TTM) in million	5,269	4,837	4,639	4,792	4,689
Return On Assets (TTM)	5.77 %	5.33 %	5.13 %	5.32 %	5.27 %
MDT's Total Ranking	# 1351	# 1152	# 1150	# 1157	# 1445
Total Assets (TTM) in million	93,306	92,950	87,640	91,346	90,972
Seq. Total Assets Change	0.38 %	6.06 %	-4.06 %	0.41 %	-0.91 %
Seq. Net Income Change	17.47 %	9.48 %	-16.73 %	31.9 %	-1.32 %

MDT's 5 Years Annual ROA >> Back to MDT Management Effectiveness >> Compare MDT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 49
Sector	# 171
Overall	# 1248

Return On Assets Statistics
High	Average	Low
14.91 %	7.39 %	2.46 %
(July 26. 2006)		(Oct 26 2018)

Financial Statements
Medtronic Plc's Assets	$ 93,306 million	MDT's Balance sheet
Medtronic Plc's Income	$ 1,479 million	Quarterly MDT's Income Statement
MDT's Income by Division		See MDT's Income by Division

Annual Return On Assets	(Apr 24 2026) FY 2026	(Apr 25 2025) FY 2025	(Apr 26 2024) FY 2024	(Apr 28 2023) FY 2023	(Apr 29 2022) FY 2022
Y / Y Total Assets Change	6.06 %	1.52 %	-1.31 %	-0.12 %	-2.6 %
Total Assets in million	92,950	87,640	86,324	87,471	87,578
Y / Y Net Income Change	3.11 %	26.61 %	-2.09 %	-25.25 %	39.45 %
Net Income in million	4,837	4,691	3,705	3,784	5,062
Annual Return On Assets	5.2 %	5.35 %	4.29 %	4.33 %	5.78 %

MDT's 5 Years Annual ROA >> Back to MDT Management Effectiveness >> Compare MDT ROA to its Competitors

Comment on MDT's ROA in the fiscal year ending 2026

In the fiscal year 2026 ROA deteriorated to 5.2 %, despite annual net income growth of 3.11 % to $4,837.00 million, from $4,691.00 million a year ago, as MDT's assets increase to $92,950.00 million, by 3.11 %.

More Return On Assets Ratios
MDT's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MDT's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MDT's Competitors
Subscribers only: Roa for Medtronic Plc's Suppliers
Subscribers only: Return On Assets for MDT's Customers

You may also want to know
MDT's Roi	MDT's Inventory Turnover Ratio	MDT's Growth Rates	MDT's Dividend Comparisons
	MDT's Profitability Ratios	MDT's Asset Turnover Ratio	MDT's Dividend Growth
MDT's Roe	MDT's Valuation Ratios	MDT's Financial Strength Ratios	MDT's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 31 2026, within Healthcare Sector	ROA
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %
Msa Safety Inc	12.23 %
Strata Critical Medical Inc	12.18 %
Insulet Corporation	12.13 %
Lantheus Holdings Inc	11.89 %
Ligand Pharmaceuticals Incorporated	11.68 %
Theravance Biopharma inc	11.68 %
Carlisle Companies Incorporated	11.62 %
Encompass Health Corporation	11.60 %

Date modified: 2026-09-19T05:00:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.